DE602006003337D1 - Medikament aus laminarin oder oligolaminarinen zur behandlung von septikämie und schock - Google Patents

Medikament aus laminarin oder oligolaminarinen zur behandlung von septikämie und schock

Info

Publication number
DE602006003337D1
DE602006003337D1 DE602006003337T DE602006003337T DE602006003337D1 DE 602006003337 D1 DE602006003337 D1 DE 602006003337D1 DE 602006003337 T DE602006003337 T DE 602006003337T DE 602006003337 T DE602006003337 T DE 602006003337T DE 602006003337 D1 DE602006003337 D1 DE 602006003337D1
Authority
DE
Germany
Prior art keywords
septicemia
medicament
treatment
shock
oligolaminarin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006003337T
Other languages
English (en)
Inventor
Jean-Claude Yvin
Nathalie Delzenne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Goemar SA
Original Assignee
Laboratoires Goemar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Goemar SA filed Critical Laboratoires Goemar SA
Publication of DE602006003337D1 publication Critical patent/DE602006003337D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602006003337T 2005-05-18 2006-05-18 Medikament aus laminarin oder oligolaminarinen zur behandlung von septikämie und schock Active DE602006003337D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504983A FR2885812B1 (fr) 2005-05-18 2005-05-18 Medicament a base de laminarine ou d'oligolaminarines pour le traitement de la septicemie et du choc septique
PCT/FR2006/001129 WO2006123059A1 (fr) 2005-05-18 2006-05-18 Medicament a base de laminarine ou d’oligolaminarines pour le traitement de la septicemie et du choc septique

Publications (1)

Publication Number Publication Date
DE602006003337D1 true DE602006003337D1 (de) 2008-12-04

Family

ID=36121515

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006003337T Active DE602006003337D1 (de) 2005-05-18 2006-05-18 Medikament aus laminarin oder oligolaminarinen zur behandlung von septikämie und schock

Country Status (8)

Country Link
US (1) US20080227748A1 (de)
EP (1) EP1888092B1 (de)
JP (1) JP5238957B2 (de)
AT (1) ATE411810T1 (de)
CA (1) CA2609080C (de)
DE (1) DE602006003337D1 (de)
FR (1) FR2885812B1 (de)
WO (1) WO2006123059A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090123637A1 (en) * 2005-05-18 2009-05-14 Laboratoires Goemar Novel Food Ingredient and Products Containing the Same
ES2333259T3 (es) * 2005-11-21 2010-02-18 Bioatlantis Limited Composiciones destinadas a mejorar la salud intestinal y el rendimiento en animales que comprenden beta-glucanos y alfa-fucanos.
JP6372890B2 (ja) * 2013-03-08 2018-08-15 学校法人東京理科大学 乳酸菌増殖促進剤、制御性ｔ細胞増加剤、乳酸菌増殖促進方法、制御性ｔ細胞を増加させる方法、制御性ｔ細胞増加効果の評価方法、および乳酸菌増殖促進効果の評価方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816213B1 (fr) * 2000-11-03 2005-04-22 Goemar Lab Sa Medicament anti-inflammatoire et cicatrisant
US6660722B2 (en) * 2001-11-30 2003-12-09 Laboratoires Goemar S.A. Therapeutical treatments

Also Published As

Publication number Publication date
EP1888092A1 (de) 2008-02-20
FR2885812A1 (fr) 2006-11-24
JP5238957B2 (ja) 2013-07-17
WO2006123059A1 (fr) 2006-11-23
US20080227748A1 (en) 2008-09-18
CA2609080A1 (fr) 2006-11-23
EP1888092B1 (de) 2008-10-22
ATE411810T1 (de) 2008-11-15
CA2609080C (fr) 2014-11-18
FR2885812B1 (fr) 2007-07-27
JP2008545646A (ja) 2008-12-18

Similar Documents

Publication Publication Date Title
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ATE440508T1 (de) Verfahren zur behandlung und/oder vorbeugung von infektionen bei kleinkindern, die über kaiserschnitt geboren werden
MX2008001652A (es) Copolimeros de poliamonio-polisiloxano.
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
FI20050023A (fi) Puun käsittelyaine, menetelmä puun käsittelemiseksi ja puutuote
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
DE602006019468D1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
WO2008105934A3 (en) Inactivation of toxic agents and pathogens using chitosan
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
UA92593C2 (ru) Лечение мастита энрофлоксацином
TW200726763A (en) Novel compound
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
ATE433459T1 (de) Desoxo-nonadepsipeptide
ATE455789T1 (de) Substituierte nonadepsipeptide
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
WO2006123164A3 (en) Lps-binding and bactericidal cytokines and interferons
DE602006003337D1 (de) Medikament aus laminarin oder oligolaminarinen zur behandlung von septikämie und schock
ATE524488T1 (de) Lysobactinamide
ATE371461T1 (de) Verwendung von extrakten aus wurzeln von pelargonium sidoides und/oder pelargonium reniforme
DE602006018725D1 (de) Amidin-derivate zur verwendung in der vorbeugung oder behandlung von glaukom
ATE474582T1 (de) Pharmazeutische zusammensetzung enthaltend glucan aus mikroalgen
ATE427754T1 (de) Verwendung von il-17f zur behandlung und/oder pravention von neurologischen erkrankungen
DE502004011486D1 (de) Antioxidationsmittel für organisches material und verfahren zur behandlung desselben
DE602004012759D1 (de) Behandlung von fibrosen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE VON KREISLER, SELTING, WERNER, 5066